TGFA Antikörper
Kurzübersicht für TGFA Antikörper (ABIN7865750)
Target
Alle TGFA Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
Klon
-
-
Verwendungszweck
- anti-TGF-alpha mouse monoclonal, 1E8-G6, purified
-
Aufreinigung
- affinity chromatography
-
Immunogen
- synthetic TGF-alpha 34-43 decapeptide linked carrier
-
Isotyp
- IgM kappa
-
-
-
-
Applikationshinweise
-
FACS_dilution: 0.5-1,0 μg/million cells in 0.1 ml
IHC-paraffin_dilution: 1:50-1:100 (1-2 μg/mL, microwave treatment in 10 mM citrate buffer pH 6.0 recommended)
WB_dilution: 1:50-1:100 (1-2 μg/mL)
IHC-frozen_dilution: 1:50-1:100 (1-2 μg/mL)
elisa_dilution: assay dependent
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Liquid
-
Konzentration
- 100 μg/mL
-
Buffer
- PBS with 0.02 % sodium azide
-
Konservierungsmittel
- Sodium azide
-
Vorsichtsmaßnahmen
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Lagerung
- 4 °C
-
Informationen zur Lagerung
- store at 2 - 8 °C
-
-
- TGFA (Transforming Growth Factor, alpha (TGFA))
-
Andere Bezeichnung
- TGF-alpha
-
Hintergrund
- 1E8-G6 reacts with TGF-alpha and shows no cross-reaction with EGF and the neuropeptide synenkephalin. 1E8-G6 is completely blocked by the peptide used for immunization. TGF-alpha (aa50) is a growth factor with 33 % homology to EGF, binds to EGFR, activates tyrosine phosphorylation of the receptor, and stimulates cell proliferation. It plays a role in tumor initiation by inducing the reversible transformed phenotype. In sections both cytoplasma and cell membranes are stained. Positive control: Jurkat or Ramos cells. testicular carcinoma, breast cancer.
-
Pathways
- NF-kappaB Signalweg, RTK Signalweg, EGFR Signaling Pathway
Target
-